Radiation Oncology/Therapy: Page 378

Auto breast US handily spots lesions in early study
By Shalmali Pal
Automated breast ultrasound (ABUS) has proved to be as effective as handheld ultrasound (HHUS) for identifying lesions, according to a pilot study out of the Elizabeth Wende Breast Clinic in Rochester, NY. The technique has potential as a screening adjunct to mammography, according to the lead author.
January 12, 2006
CMS increases Gamma Knife reimbursement
By AuntMinnie.com staff writers
Swedish radiation therapy and oncology device developer Elekta said that the U.S. Centers for Medicare and Medicaid Services (CMS) has raised the reimbursement payment for cobalt-60-based stereotactic radiosurgery, which includes Gamma Knife treatment delivery.
January 11, 2006
Trimming CT dose decreases lung CAD performance
By Erik L. Ridley
The lower the CT dose, the lower the performance of computer-aided detection (CAD) systems in detecting lung nodules, according to researchers from Samsung Medical Center (SMC) in Seoul, South Korea.
January 11, 2006
TomoTherapy adds to coffers
By AuntMinnie.com staff writers
Radiation therapy developer TomoTherapy said it raised $14 million of new equity capital in late December.
January 10, 2006
NAS nets Chinese tomotherapy contract
By AuntMinnie.com staff writers
Radiation therapy firm North American Scientific said it has delivered the first order for its Peacock treatment planning software and ancillary products to an oncology hospital in the People's Republic of China.
January 9, 2006
NAS fiscal 2005 results impacted by Nomos purchase
By AuntMinnie.com staff writers
Radiation therapy firm North American Scientific reported fiscal 2005 fourth-quarter revenue of $6.9 million, down 30% compared with the $9.8 million posted a year ago.
January 9, 2006
Minrad promotes Bednarski
By AuntMinnie.com staff writers
Minrad has promoted executive vice president and COO William Bednarski to president and CFO.
January 8, 2006
GE, PhotoCure ink optical imaging deal
By AuntMinnie.com staff writers
GE Healthcare and PhotoCure have inked a licensing agreement covering the Oslo, Norway-based firm's Hexvix optical molecular imaging agent for diagnosing and monitoring bladder cancer.
January 8, 2006
I-ELCAP data suggest need to work up secondary lung lesions
By Eric Barnes
Lung cancer screening data from the I-ELCAP trial suggest that patients with secondary tumors might benefit from more aggressive management, and that metastases, at least in the predominant non-small cell lung cancers, may be less common than previously thought. The data also suggest that revisions in the current staging criteria may help save lives.
January 8, 2006
MRI and cancer diagnosis
MRI utilization has been climbing at double-digit rates for decades. This is due largely to the modality's financial success and new clinical applications. But perhaps the biggest news to hit MRI, from both financial and clinical perspectives, will be the burgeoning use of MR in oncology, according to MRI architectural consultants Robert Junk and Tobias Gilk.
January 5, 2006
Permanent seeds show promise in breast cancer therapy
By Brian Casey
January 4, 2006
FDA clears Xoft brachytherapy unit
By AuntMinnie.com staff writers
Brachytherapy device developer Xoft has received FDA clearance for a new brachytherapy device designed to target breast cancer.
January 4, 2006
Previous Page
Page 378 of 469
Next Page